Cameron John Reynolds - President and CEO, Director at VOLITIONRX LTD

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
VNRX on NYSE
All Insider Reports
All Insider Reports

Cameron John Reynolds - trading volume in the past year for VOLITIONRX LTD

Holdings reported by Cameron John Reynolds for VOLITIONRX LTD

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3,115,547 $778,886 $0.2500 26 Feb 2026 Direct
Common Stock 1,007,718 $251,929 $0.2500 26 Feb 2026 By Concord International, Inc.
Common Stock 34,076 $8,519 $0.2500 26 Feb 2026 By Spouse
Warrant (Right to Buy) 110,000 14 Oct 2025 Direct Common Stock

Transactions reported by Cameron John Reynolds for VOLITIONRX LTD

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.